Two people can be born in the same year, live through the same decades, and arrive at 70 in completely different states. One is sharp, active, and healthy. The other is frail and forgetful. Chronological age — the number of candles on the cake — tells you almost nothing about this difference. Biological age, measured at the cellular level, tells you far more.
Scientists have been building tools to measure it for years. Now a Harvard-led team has produced what may be the most powerful and interpretable version yet — a genetic clock that works across multiple species and responds to known anti-ageing interventions in ways that suggest it’s tracking something real.
The Problem With Existing Clocks
The field of biological age measurement has developed rapidly. Blood protein clocks, metabolic clocks, multi-omics clocks — each takes a different angle on the same underlying question:
How worn out are your cells, really? The most celebrated of all are epigenetic clocks, which read the chemical tags that accumulate on DNA over time and shift in response to lifestyle, stress, diet, and disease. These have proven remarkably good at predicting disease risk and even life expectancy.
Their weakness is interpretability. The DNA methylation patterns they measure are statistically powerful but mechanistically murky — scientists can see the patterns correlating with age, but struggle to explain exactly why those particular chemical changes are happening, or what they mean biologically. The clock works; the mechanism remains debated.
A More Readable Clock
The new Harvard clock takes a different approach, measuring gene activity — technically called the transcriptome — rather than DNA methylation. At any given moment, some of your genes are switched on and others off. The pattern of which genes are active reflects the current state of your cells: their energy levels, how inflamed they are, whether they’re in repair mode or starting to fail.
Because these patterns correspond to specific biological processes, they are far easier to interpret than epigenetic signatures. When the clock detects accelerated ageing, researchers can see which genes are responsible — and understand what those genes actually do.
The dataset behind the clock is substantial: over 11,000 gene activity profiles drawn from mice, rats, monkeys, and humans, including thousands of samples from a major US programme testing longevity interventions in mice. Crucially, the dataset included animals that had been exposed to known anti-ageing treatments — including parabiosis, where older animals receive blood from young donors, a strategy shown to have rejuvenating effects in rodent studies.
What the Clock Found
The clock performed well on independent validation datasets, accurately predicting lifespans in a large human heart health study and responding appropriately to conditions known to accelerate or slow ageing. Radiation and chronic disease pushed the clock forward. Young blood transfusion wound it back.
When the researchers analysed which genes were driving the clock’s readings, familiar suspects emerged: genes involved in chronic inflammation, failing mitochondria, and cellular senescence — the process by which damaged cells stop dividing but remain metabolically active, leaking toxic signals that harm surrounding tissue. Many of these signatures appeared consistently across organs and across species, suggesting that the core molecular machinery of ageing is broadly conserved in mammals.
That cross-species consistency has practical value. Mice live for a fraction of a human lifespan, making them useful research subjects but difficult to use for lifespan studies that must run to their natural conclusion. A clock that can accurately read biological age and predict remaining lifespan in rodents — and that responds to interventions in the expected direction — could dramatically accelerate the testing of anti-ageing treatments, yielding meaningful signals in months rather than years.
The Honest Caveats
The clock is not ready for clinical use, and its creators are straightforward about why.
The most fundamental uncertainty is causation. The gene activity patterns the clock detects could be driving ageing — or they could simply be reflecting it, a downstream symptom rather than an upstream cause. Some of the age-related changes the clock captures may even represent the body’s attempt to fight back against deterioration, protective responses rather than signs of damage. Distinguishing between genes that contribute to ageing and genes that defend against it remains an unsolved problem.
There’s also the broader challenge that faces the entire field of biological clocks: they don’t always agree with each other. Different clocks, built from different biological signals, sometimes produce meaningfully different estimates of the same person’s biological age. That inconsistency is a reminder that ageing is not a single process but a complex, multi-layered phenomenon that no single measurement can fully capture.
Why It Still Matters
Despite those caveats, a more interpretable clock that works across species and responds to known interventions is a genuine advance. For longevity researchers, it offers a clearer window into which molecular processes a given treatment is actually affecting — and how much. For the longer-term ambition of developing therapies that slow or reverse ageing in humans, that clarity is not a minor detail. It’s the difference between knowing something works and understanding why.
The question of how fast any individual is ageing may not yet have a clinical answer. But the tools to answer it are getting sharper.